CDKN2A and cancer: There is compelling genetic evidence from numerous cancer studies that p16/INK4A is a critical tumor suppressor gene whose direct inactivation by point mutation, deletion, or promoter hypermethylation is observed in nearly one third of human cancers, establishing its loss as one of the most frequent lesions promoting human malignancy [37].